Compare STOK & NIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STOK | NIC |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2019 | N/A |
| Metric | STOK | NIC |
|---|---|---|
| Price | $33.14 | $130.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $31.00 | ★ $145.33 |
| AVG Volume (30 Days) | ★ 880.4K | 114.5K |
| Earning Date | 11-04-2025 | 01-20-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | N/A | ★ 18.84 |
| EPS | 0.68 | ★ 9.34 |
| Revenue | $205,632,000.00 | ★ $375,962,000.00 |
| Revenue This Year | $430.24 | N/A |
| Revenue Next Year | N/A | $5.09 |
| P/E Ratio | $45.09 | ★ $13.93 |
| Revenue Growth | ★ 1128.17 | 9.68 |
| 52 Week Low | $5.35 | $97.90 |
| 52 Week High | $38.69 | $141.92 |
| Indicator | STOK | NIC |
|---|---|---|
| Relative Strength Index (RSI) | 65.66 | 59.98 |
| Support Level | $28.74 | $124.79 |
| Resistance Level | $31.44 | $130.39 |
| Average True Range (ATR) | 1.83 | 2.58 |
| MACD | 0.38 | 0.91 |
| Stochastic Oscillator | 95.76 | 86.59 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.